Is Athira Pharma Inc (NASDAQ: ATHA) The Best Stock To Invest In?

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

Athira Pharma Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Athira Pharma Inc is $30.94M. A total of 3.52 million shares were traded on the day, compared to an average of 5.06M shares.

In the most recent transaction, Mark James Litton bought 5,032 shares of ATHA for 0.00 per share on Sep 05 ’24. In a previous transaction on Sep 05 ’24, Gengos Andrew sold 1,272 shares at 0.57 per share. ATHA shares that CFO and Chief Business Officer owns now total 97,532.

Among the insiders who sold shares, Lenington Rachel disposed of 2,525 shares on Sep 05 ’24 at a per-share price of $0.57. This resulted in the COO and CDO holding 20,870 shares of ATHA after the transaction. In another insider transaction, CHURCH KEVIN sold 2,525 shares at $0.57 per share on Sep 05 ’24. Company shares held by the CHIEF SCIENTIFIC OFFICER now total 92,684.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, ATHA has a high of $4.30 and a low of $0.41.

As of this writing, ATHA has an earnings estimate of -$0.45 per share for the current quarter. EPS was calculated based on a consensus of 5.0 estimates, with a high estimate of -$0.23 per share and a lower estimate of -$0.67. The company reported an EPS of -$0.71 in the last quarter

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. ATHA’s latest balance sheet shows that the firm has $253.76M in Cash & Short Term Investments as of fiscal 2021. There were $1.92M in debt and $9.29M in liabilities at the time. Its Book Value Per Share was $1.49, while its Total Shareholder’s Equity was $321.08M.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ATHA is Buy with a score of 3.00.

Most Popular

Related Posts